Literature DB >> 28969183

Meropenem Induced Hypokalemia.

T V Anuhya1, Raviraj Acharya2, Sharath MadhyasthaA2, Ram Bhat2, Veena Nayak3.   

Abstract

Meropenam, a beta-lactam antibiotic has been used for severe infections of skin, tissue, intra- abdominal and urogenital infections in hospitalized patients. The common adverse effects reported are diarrhoea, vomiting, rashes and hypersensitivity reactions. Here we report two cases of meropenam induced hypokalemia, wherein, meropenam was prescribed for cellulitis and urinary tract infection in the first and second case respectively. Hypokalemia can manifest as muscular weakness, fatigue, muscle cramps, constipation, ileus, flaccid paralysis, hyporeflexia, hypercapnia, tetany, rhabdomyolysis or respiratory failure. Hence, it is necessary to make physicians aware of such an adverse effect which can develop with meropenam.

Entities:  

Keywords:  Antibacterial agents; Beta-lactam antibiotics; Hypokalemia; Infections

Year:  2017        PMID: 28969183      PMCID: PMC5620824          DOI: 10.7860/JCDR/2017/27584.10387

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  2 in total

1.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

2.  Meropenem-induced hypokalemia and metabolic alkalosis.

Authors:  Syed Ahmed Zaki; Preeti Shanbag
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

  2 in total
  1 in total

1.  Lethal Arrhythmia (Torsade de Pointes) in COVID-19: An Event Synergistically Induced by Viral Associated Cardiac Injury, Hyperinflammatory Response, and Treatment Drug?

Authors:  Nuraini Yasmin Kusumawardhani; Ian Huang; Erwan Martanto; Teddy Arnold Sihite; Eka Surya Nugraha; Susantina Prodjosoewojo; Laniyati Hamijoyo; Yovita Hartantri
Journal:  Clin Med Insights Case Rep       Date:  2020-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.